Authors



Alexander White, PharmD Candidate

Latest:

Takeda Pharmaceuticals America, Inc's Edarbi

The FDA approved Edarbi (azilsartan medoxomil), a new angiotensin receptor blocker, for the treatment of hypertension in adults.



Audrey Schnell, PharmD Candidate

Latest:

Working Outside the Dispensing Box: The Roles of the Medical Information Specialist and Medical Science Liaison

As medical information specialists and medical science liaisons, pharmacists use their drug expertise and clinical skills to serve as information providers


Erin Albert, MBA, PharmD, JD

Latest:

Pair Up, Publish, Promote, and Prosper: Why and How to Write Before You Graduate from Pharmacy School

Don’t leave behind your writing passion if you head to pharmacy school; instead, leverage it as a way to share with others what you’ve learned in school.


Karen Berger, PharmD

Latest:

Clyde Pharmacy Celebrates Community in Oklahoma City

Greg Clyde, PharmD, shares his love of pharmacy with patients in oklahoma.


Amy Heck Sheehan, PharmD

Latest:

Medication Formulary Management in a Large, Multihospital System

Clarian Health, an 11-hospital health system, developed and managed a multihospital formulary through focused planning and collaboration.


Charles L. Browne III, JD

Latest:

Coping with Terminal Illness

Pharmacists are the key position to help patients cope with serious illness and adjust their lifestyles to their conditions. Here is the practical guide for counseling patients living with these life changing health concerns.


Stephen W. Erickson, PhD

Latest:

Self-Reported Plan Switching in Medicare Part D: 2006-2010

Less than one-fourth of Part D beneficiaries reported switching plans. Elderly beneficiaries who reported switching did not realize significant savings in prescription costs over nonswitchers.


Krystalyn Weaver, PharmD

Latest:

Provider Status in the States

State pharmacy associations are working to advance provider status legislation at the state and federal levels.


Gary C. Steven, MD, PhD

Latest:

Guidelines for Collaboration Among Physicians, Pharmacists, and Managed Care Organizations to Improve Asthma Outcomes

New ideas, new tools, and new collaborations among managed care, physicians, and pharmacy to optimize value in asthma management.



Anil Mallya, PharmD

Latest:

Medicare Part D Optimization: Potential Out-of-Pocket Savings Through Plan Reexamination

Medicare Part D plans can change their cost-sharing structure and formularies every year. As such, beneficiaries should annually reevaluate plan offerings to minimize their out-of-pocket costs.



Raquel Dina, PharmD

Latest:

Edwin's Prescription Pharmacy: Servicing the Specialty Medication Needs of Long-Term Care Patients

Overcoming the challenges to meet the special needs of long-term care patients, this pharmacy provides a careful approach that provides positive results.


Robert Dutcher, PharmD

Latest:

Guidelines Recommend ACE Inhibitor or ARB for Heart Failure

Dr. Dutcher is a registered pharmacist based in Punta Gorda, Fla.


Matthew P. Pietry, PharmD Candidate

Latest:

Keep an Eye on Protein Kinase Inhibitors

Medications in this drug class can alter the safety and efficacy of co-administered medications.


Gary E. Myerson, MD

Latest:

Pharmacoeconomics of ColciGel for the Treatment of Acute Gout Flares

The pharmacoeconomic impact of treating acute gout flares with ColciGel or with oralcolchicine.


Nick S. Poulios, PhD

Latest:

Drug Coverage and Decision Making in Medicare Part D Enrollees

This pharmacy adjudication, prescription fulfillment study demonstrates how a sudden drop of prescription drug coverage has an effect on Medicare Part D patients' prescription decisions.



Edward G. Mauceri, MD

Latest:

Value-Based Benefit Design and Healthcare Utilization in Asthma, Hypertension, and Diabetes

A value-based benefit design program for prescription medications for asthma, hypertension, and diabetes could result in increased prescription use and decreased healthcare utilization and costs.


Samuel Stolpe, PharmD

Latest:

New Challenges and Opportunities in Immunization Quality Metrics

In the United States, adult immunization rates are substandard. Opportunities exist to improve these rates trough quality performance measurement, but not without challenges.


Fred M. Eckel, RPh, MS, Pharmacy Time Editor-in-Chief

Latest:

Five Major Issues Facing Pharmacy

How these issues are handled will have a major impact on the future of pharmacy practice.


Einav Keet

Latest:

Hepatitis C Treatment Duration Could Be Slashed for Some Patients

Direct-acting antivirals are a costly but highly-effective class of drugs for the treatment of hepatitis C that can cure most cases.



Chelsea Childs

Latest:

Antidepressant Discontinuation: What the Tertiary Databases and Package Insert Tells You

Discontinuation of antidepressants should take place gradually, as abrupt stoppage or marked reduction in the dosage of an antidepressant is frequently associated with adverse effects (AEs), such as withdrawal symptoms.




Stephanie Gernant, PharmD, MS

Latest:

Pharmacist Technicians Can Play Key Role in Push Toward Telemedicine During COVID-19 Pandemic

Lessons from implementing electronic medical records should be heeded by allowing clinicians to focus on patient care and by delegating the management of telemedicine to support staff, such as pharmacy technicians.


OncLive Staff

Latest:

Catch Up with Highlights from ASCO

Top news of the week from the annual meeting of the American Society of Clinical Oncology.